Martina Frodlund (M Frodlund)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Microbiology spectrum

Lupus

Clinical and experimental immunology

Cells

Linköpings universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Linköpings universitet May 30 2015

Sweden

PHD :: Rheumatology department

Publications

Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg, Monica Hansson, Sophie Ohlsson, Elisa Pin, Anders Bengtsson, Lars Klareskog, Meliha Crnkic Kapetanovic
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA). Microbiology spectrum 12 (4) (2024)
Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg, Monica Hansson, Sophie Ohlsson, Elisa Pin, Anders Bengtsson, Lars Klareskog, Meliha Crnkic Kapetanovic
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA). Microbiology spectrum (2024)
Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg, Monica Hansson, Sophie Ohlsson, Elisa Pin, Anders Bengtsson, Lars Klareskog, Meliha Crnkic Kapetanovic
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA). Microbiology spectrum 12 (4) (2024)
Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg, Monica Hansson, Sophie Ohlsson, Elisa Pin, Anders Bengtsson, Lars Klareskog, Meliha Crnkic Kapetanovic
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA). Microbiology spectrum 12 (4) (2024)
Jasmin Knopf, Johanna Sjöwall, Martina Frodlund, Jorma Hinkula, Martin Herrmann, Christopher Sjöwall
NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic. Cells 11 (17) (2022)
Rebecca Heijke, Mathilda Björk, Martina Frodlund, Laura McDonald, Evo Alemao, Christopher Sjöwall
Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus. Lupus 29 (6) (2020)
Martina Frodlund, S Reid, Jonas Wetterö, Ö Dahlström, Christopher Sjöwall, D Leonard
The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts. Lupus 28 (10) (2019)
Martina Frodlund, Jonas Wetterö, C Dahle, Ö Dahlström, T Skogh, J Rönnelid, Christopher Sjöwall
Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease. Clinical and experimental immunology 199 (3) (2019)

Martina Frodlund.css-eqlu8i{font-size:small;padding-left:4px;} (M Frodlund)

Publication Activity (10 Years)

Top Topics

Top Venues

Martina Frodlund (M Frodlund)